Digital Diabetes Self Management Education and Support for Patients With Type 2 Diabetes
Reason given: Interim analysis of primary outcome (HbA1c at 6 months) revealed no numerical differences after 80 included participants. Further inclusion of participants to reach prespecified N to evaluate primary outcome deemed futile. 138 participants included.
Key facts
- Where
- Boxholm, Eksjö, Gislaved, Huskvarna, Jönköping, Kalmar, Linköping, Västervik, and Vetlanda, SwedenSee the 15 sites
Where in Sweden
- Boxholms vårdcentralBoxholm, SwedenNo longer taking part
- Eksjö vårdcentralEksjö, SwedenNo longer taking part
- Gislaved vårdcentralGislaved, SwedenNo longer taking part
- Rosenhälsans vårdcentralHuskvarna, SwedenNo longer taking part
- Gränna vårdcentralJönköping, SwedenNo longer taking part
- Lokstallarna vårdcentralJönköping, SwedenNo longer taking part
- Norrahammars vårdcentralJönköping, SwedenNo longer taking part
- Råslätts vårdcentralJönköping, SwedenNo longer taking part
- WetterhälsanJönköping, SwedenNo longer taking part
- Kvarnholmens hälsocentralKalmar, SwedenNo longer taking part
- Kärna VårdcentralLinköping, SwedenNo longer taking part
- Linghems vårdcentralLinköping, SwedenNo longer taking part
- Tannefors vårdcentralLinköping, SwedenNo longer taking part
- Stora Trädgårdsgatans hälsocentralVästervik, SwedenNo longer taking part
- Aroma VårdcentralVetlanda, SwedenNo longer taking part
Trial details
- Who runs it
- Region Jönköping County
- Trial code
- NCT05026528
- Record updated
- 18 December 2025
- Original description
The purpose of this study is to test the effect of using a digital diabetes self management education and support system compared with standard care for patients with type 2 diabetes in primary health care.Read full original descriptionShow less
Randomized Controlled Trial of a Digital Diabetes Self Management Education and Support System for Patients With Type 2 Diabetes in Primary Health Care
The purpose of this study is to test the effect of using a digital diabetes self management education and support system compared with standard care for patients with type 2 diabetes in primary health care.
Inclusion: Type 2 diabetes mellitus diagnosed according to WHO criteria < 5 years from randomization:; Fasting plasma glucose > 7 mmol/L at two timepoints. OR; HbA1c ≥ 48 mmol/mol twice or in combination with fasting plasma glucose > 7 mmo/L once. OR; Non-fasting plasma glucose ≥ 11.1 mmol/L at one timepoint in combination with symptoms of hyperglycemia; Access to a digital ID-card to access the digital system; Access to a computer, tablet or smart phone; Sufficient knowledge of written and spoken Swedish to understand the information given in the digital system.
Exclusion: Treatment with Insulin; Other co-morbidities limiting the use of the digital system according to the diabetes nurse judgement. E.g. dementia or severe psychiatric disease; Other forms of diabetes mellitus than type 2 diabetes.